GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMF) » Definitions » Other Operating Expense
中文

Novonesis AS (Novonesis AS) Other Operating Expense : $-12 Mil (TTM As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Other Operating Expense?

Novonesis AS's Other Operating Expense for the three months ended in Dec. 2023 was $7 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-12 Mil.

Novonesis AS's quarterly Other Operating Expense increased from Jun. 2023 ($-2 Mil) to Sep. 2023 ($-2 Mil) and increased from Sep. 2023 ($-2 Mil) to Dec. 2023 ($7 Mil).

Novonesis AS's annual Other Operating Expense declined from Dec. 2021 ($-10 Mil) to Dec. 2022 ($-11 Mil) and declined from Dec. 2022 ($-11 Mil) to Dec. 2023 ($-12 Mil).


Novonesis AS Other Operating Expense Historical Data

The historical data trend for Novonesis AS's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Other Operating Expense Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.87 -2.29 -10.03 -10.68 -12.14

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.91 -14.96 -2.18 -2.00 7.32

Novonesis AS Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Not Just Yogurt Anymore

By PRNewswire 10-26-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019